scorecardresearch
Add as a preferred source on Google
Monday, September 29, 2025
TopicDGCI

Topic: DGCI

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

Tough pill to swallow for e-pharmacies as govt’s draft bill proposes curbs on online sale of drugs

Likely to be presented to Cabinet before being tabled in Parliament, latest version of draft bill aims to regulate, restrict or ban online sale of prescription drugs.

Texas hospital’s Covid-19 vaccine Corbevax is ‘not for profit’. It’s a ‘gift to the world’

In a statement, Biological E. said it plans to manufacture 75 million doses a month, anticipating more than 100 million doses per month by February 2022.

France’s Sanofi seeks marketing nod for dengue vaccine, govt panel says identify endemic areas

The vaccine Dengvaxia has to be administered to individuals aged 9 to 45, who have been infected with the dengue virus before and who live in areas where this infection is endemic.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Covaxin & Covishield get govt nod for emergency use, stage set for Covid immunisation to begin

Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.

Drug regulator sends notice to Serum Institute over AstraZeneca vaccine trial

DCGI issued a show-cause notice to Serum Institute following reports that human trials of the Oxford vaccine were paused in UK after a candidate had an adverse reaction.

Health ministry asks DGCI to ensure equitable distribution of Remdesivir, Tocilizumab

The ministry wrote to DCGI, asking it to ascertain how many states, UTs have been covered and which of them are left, as far as the availability and distribution is concerned.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

On Camera

Bodoland poll loss a wake-up call for Assam BJP. Zubeen’s death puts CM Sarma in a tight spot

Assam CM can’t celebrate that the Congress drew a blank in the Bodoland Territorial Council polls in 2010 as well as 2015, and bagged only one in 2020.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

Aerial warfare analyst Tom Cooper faults India’s military PR, says Pakistan does it better

In post on social media, Cooper narrated experience of MiG-21 researcher from Germany who wanted to attend aircraft’s farewell ceremony in India, and the roadblocks he faced. 

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.